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described in sufficient detail for both the results 
and the conclusions deduced from them to be 
readily understood. Partial reactions are given 
before each new set of experiments, which saves a 
reader who is not actually working on the ATPase 
from having to refer continually back to a 
complete scheme. The references cover most of the 
kinetic experiments on the enzyme to 1980 and 
there is adequate discussion of disagreements 
between different workers. 
However, no other aspects of sarcoplasmic 
reticulum function are covered in this book. 
Topics such as the physiological control of calcium 
release and uptake during a contraction cycle, 
other proteins of the sarcoplasmic reticulum, 
quantitative aspects of calcium movements in 
muscle, structural studies of the calcium ATPase, 
etc. are not discussed at all. This is not meant as 
a criticism of the book, since the author 
deliberately sets out to cover one aspect of the 
subject only. It is meant as a warning that this 
book should not be bought by those expecting a 
general treatise on sarcoplasmic reticulum. It is 
written purely as a detailed review of kinetic 
studies on the calcium ATPase, and from this 
limited viewpoint can be recommended. 
P. J. England 
Progress in Clinical and Biological Research Vol. 89 
Edited by G.A. Jamieson 
Alan R. Liss; New York, 1982 
xx + 523 pages 
The two very active research fields, cancer and 
coagulation, have been moving inexorably towards 
each other during the last decade or so and 
although it is well established that clotting abnor- 
malities (second only to infections) are one of the 
major causes of death in cancer patients, the value 
of anticoagulant regimes in the treatment of 
malignancy is still very much a controversial issue. 
What is more certain, however, is that there are so 
many features of the growth and spread of 
tumours that appear to interdigitate in some way 
with the body’s haemostatic mechanisms that in- 
tensive investigations of the various factors and the 
cell to cell surface interactions on which the close 
association of these two processes depend can be 
amply justified since they may well lead to a fur- 
ther understanding of metastatic processes. 
Around twenty years ago it was first 
demonstrated in tumour-bearing animals that the 
incidence of metastases could be substantially 
reduced by decreasing the circulating plateIet 
population and some years later it was clearly 
shown that the metastatic potential of tumour cells 
in vivo roughly correlated with their capacity to ag- 
gregate platelets in vitro. Strangely, with the 
passage of time and despite the current wealth of 
knowledge we now possess about the 
physicochemical properties of the surface mem- 
branes of both platelets and tumour cells there is 
still a paucity of information on what these cell in- 
teractions may mean at the ‘small print’ molecular 
level. Clearly this was a major stimulus for 
devoting the 1981 Chesapeake Conference to this 
important topic area. The present publication, 
which is Vol. 89 in a highly regarded series dealing 
with progress in clinical and biological research, 
brings together all the major contributions to that 
conference which was organised and chaired by the 
editor. 
Inevitably when a first time conference is focuss- 
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ed on a topic which draws its enthusiasts from a 
wide spectrum of basic and clinical research with 
cell biology, pathology, pharmacology and 
biochemistry, all closely interwoven, the collected 
contributions for publication can take on the 
character of a ‘pot pourri’. The editor of this con- 
ference report is to be congratulated on achieving 
a sufficient measure of homogeneity of interests in 
the various sessions that the value of the book is 
greatly enhanced by the inclusion of 18 lively 
discussion sections interspersed throughout the 27 
major contributions. 
What is really missing from the volume, 
however, is a good introductory survey chapter, 
setting the scene as circumscribed by the Con- 
ference title, putting the field into historical 
perspective, critically analysing the progress to 
date and possibly also highlighting the potentially 
fruitful areas of future research investment. The 
opening contribution to the first session of the 
Conference, though extremely valuable with a 
well-researched bibliography, could not fulfil this 
survey role since the authors of this contribution 
set out to document all the known ~oagulopathies 
which have been reported to be associated with 
malignancy, from frank thrombosis to the involve- 
ment of more specific clotting factors. These have 
been admirably catalogued and their significance 
well discussed. Later contributors to this first ses- 
sion headed ‘Pathology and Pharmacology’ tend- 
ed to confine their interests to the effects of an- 
tiplatelet drugs in animals on tumour growth and 
metastatic spread. A number of the drugs studied, 
which are known to be effective in treating or 
preventing thromboembolism, also decreased the 
incidence of metastases but to date no large scale 
clinical trials seem to have been conducted. This 
session linked in well with the following session in 
which contributors described in vivo studies of the 
action of human tumour cells on circulating 
platelets. Of the animals proposed, two groups ad- 
vocated the nude-mouse as a model system since 
being deficient in mature T-lymphocytes it appears 
to have some value in selecting highly metastatic 
variants. The claimed stability, through con- 
tinuous mouse culture of sublines isolated in this 
way could form a basis for better standardised pro- 
cedures for testing platelet tumour cell interactions 
or the efficacy of antimetastatic agents. There are 
some complexities, however, since many human 
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tumours of proven high metastatic potential do not 
metastasise in adult mice but do so in the young 
(deficient in natural killer cells). Selection of 
metastatic variants in this way may therefore de- 
pend more upon their resistance to T-cell- 
independent defence processes rather than to 
platelet associations or cell attachment o vessel 
walls. In sessions 3 and 4 a number of the reports 
draw attention to the platelet’s ability to release, 
from internal stores, proteins, and perhaps lipid 
factors too which affect tumour cell growth rates 
and metastatic activities. This is an area of inten- 
sive activity with a number of research groups (not 
unfortunately represented at this Conference) pur- 
suing the more detailed molecular characterisation 
of the various platelet-derived growth-promoting 
factors which are likely to be released during 
tumour cell-platelet interactions. This topic war- 
rants inclusion in later conferences ince these im- 
portant factors will certainly have to be taken into 
account in the overall picture. Other participants 
in this and later sessions had investigated the in- 
teraction of tumour cells alone with vascular en- 
dothelial cells and basement membrane surfaces. 
Also by the use of a perfusion chamber model the 
association of mixed platelet/tumour cell free 
floating emboli with sections of normal and de- 
endothelialised aorta segments can be explored and 
a wider adaptation of this technique may well shed 
some light on the very early events occurring dur- 
ing blood-borne metastases. The final session of 
the Conference included papers grouped under the 
general heading ‘Biochemistry’ but the actual 
biochemical content was generally disappointing. 
Using platelet-tumour celi aggregation some at- 
tempts had been made to study the cell surface 
molecular features on which the association might 
depend but though certain sialoglycoproteins and 
membrane phospholipid integrity appear to be im- 
portant features, thrombin generation and ADP 
released from activated platelets add extra dimen- 
sions of complexity in understanding the events. 
There are, however, many useful and significant 
contributions in this volume which should interest 
oncologists, haematologists, immunologists, phar- 
macologists and biochemists but readers wiil have 
to chart their own course through the 27 contribu- 
tions and reference lists to appraise the current 
state of knowledge with respect to their own 
disciplinary interests since the field encompasses 
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almost the whole of cell biology. Some advances 
have clearly been made and some interesting and 
testable concepts are emerging but as a cry for in- 
creasing investment in this important area of 
tumour biology the progress so far from 
‘phenomenology’ towards a more molecular 
understanding of these cell interactions has been 
disturbingly slow, as represented by the work 
presented in this volume. 
N. Crawford 
Histological and Histochemical Methods: Theory and Practice 
by J.A. Kiernan 
Pergamon Press; Oxford, 1981 
344 pages. ~529.00 (hardback), f10.50 (paperback) 
This book describes in twenty chapters the basic 
staining and other histochemical reactions com- 
monly used when preparing biological material for 
light microscopy. It is assumed by the author that 
the reader has a knowledge of chemistry and 
biology, a little higher than that found in the last 
year University courses of North America, and the 
work appears to be written for those about to em- 
bark on a career in a histological laboratory, but 
this is not stated by publisher or author. The 
earlier part of the book deals with the fixation of 
tissue and the processing and mounting of sec- 
tions, and does not discuss in any detail the techni- 
ques of embedding and section cutting. The 
longest chapter deals with the classification and 
chemical reactions of dyes and indicates their uses 
in histochemistry. Subsequent chapters deal with 
methods designed to demonstrate particular struc- 
tures or substances. In each the basic chemistry is 
discussed and details of the individual methods 
described. Each chapter ends with a brief set of 
theoretical and practical exercises. Neurohisto- 
logical techniques are considered separately and a 
final chapter discusses basic immunochemistry. 
Throughout this book the main concern of the 
author is with the basic chemistry of the techniques 
described. Little guidance is given in the choice of 
method for any particular purposes, and there is 
minimal concern with pathological conditions. 
Amyloid, for example, is only briefly mentioned in 
the section on glycoproteins and the reader refer- 
red to a standard work for details of the various 
staining techniques. However, for the student 
looking for insight into the chemistry behind many 
standard staining techniques, this work should 
prove valuable. It may also prove of use to the 
worker with little histochemical background who 
needs to use an histological technique as part of his 
researches. Both will find the bibliography referr- 
ing to standard texts as well as a wide variety of 
original papers and review articles useful. To the 
beginner, the simple approach to complex 
chemistry will be welcome. 
J.E. McLaughlin 
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